August 2016

August 2016

August 2016 Issue

Features

  • A little DED advice: Prescribe to variety

    By Karen Blum, Contributing Editor

    With only two FDA-approved drugs for dry eye disease, it’s good to have more than a Plan B.

  • A NOD to a painful, puzzling diagnosis

    By Richard A. Adler, MD

    Nonobvious dry eye disease may have a neuropathic basis, so look for symptoms; signs might prove elusive.

  • DED surveys: reality v. perception

    By Laura M. Periman, MD

    Physicians say they talk to patients about the dangers lurking in cosmetics; patients say otherwise.

  • Does symptom-free mean dry eye-free?

    By Wendy Lyons Sunshine

    No: nerve damage, systemic conditions and environmental factors can contribute to asymptomatic dry eye.

  • Giving birth to a dry eye clinic

    By Patti Barkey, COE, Sheetal Shah, MD, and Zachary Smith, MHSA

    DED mavens — two established, one en route — provide pearls, expose pitfalls and show how it’s done.

  • Heading for the exit?

    By Robert Calandra, Contributing Editor

    Are ophthalmologists retiring due to the heavy hand of the government?

  • When beauty doesn’t blink

    By Laura M. Periman, MD and Leslie E. O’Dell, OD

    We look at exacerbators of ocular surface disease that lurk on product labels in cosmetics bags.

Departments